生物制药公司Outlook Therapeutics, Inc.近日宣布一项重要人事任命——Laura Cantrell正式加入公司管理层，担任企业战略与业务发展副总裁一职。此次任命将强化公司在眼科生物制剂领域的战略布局，Cantrell女士将主导全球商业合作机会的挖掘与战略规划体系的优化。
拥有超过15年生物制药行业经验的Cantrell，曾在美国知名药企担任高级管理职务，在跨境许可协议谈判、产品管线战略规划等领域具有丰富实战经验。她的加盟将助力Outlook Therapeutics推进核心产品ONS-5010的商业化进程，并为公司未来在视网膜疾病治疗领域的创新研发注入新动能。
首席执行官Russell Trenary表示："Laura在生物制药商业拓展领域的卓越履历，与公司现阶段发展需求高度契合。她将带领团队加速实现我们成为眼科领域领导者的愿景。"据悉，Cantrell将直接向Trenary汇报工作，并参与制定公司长期发展战略。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.